| Description | Ginsenoside Rk1 has anti-tumor, and anti-platelet aggregation activities. |
| In vitro | Their structure were determined to be 3beta,12beta-dihydroxydammar-20(21),24-diene-3-O-beta-D-glucopyranosyl(1 --> 2)-beta-D-glucopyranoside; 3beta,12beta-dihydroxydammar-20(21),24-diene-3-O-beta-D- glucopyranoside and 3beta,6alpha,12beta-trihydroxydammar-20(21),24-diene-6-O-beta-D-glucopyranoside based on spectroscopic evidences. |
| Synonyms | 人参皂苷RK2 |
| molecular weight | 604.869 |
| Molecular formula | C36H60O7 |
| CAS | 364779-14-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Three new dammarane glycosides from heat processed ginseng.Arch Pharm Res. 2002 Aug;25(4):428-32. |